Procter Gamble Health Ltd vs Shree Ganesh Biotech India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5334 as of 06 May 15:30 . The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The p/e ratio of Shree Ganesh Biotech India Ltd changed from 90 to 52.5 over 5 quarters. This represents a CAGR of -35.03% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The market cap of Shree Ganesh Biotech India Ltd changed from ₹ 35.88 crore to ₹ 41.86 crore over 5 quarters. This represents a CAGR of 13.12% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The revenue of Shree Ganesh Biotech India Ltd for the Dec '25 is ₹ 1.07 crore as compare to the Sep '25 revenue of ₹ 1.18 crore. This represent the decline of -9.32% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The ebitda of Shree Ganesh Biotech India Ltd for the Dec '25 is ₹ 0.32 crore as compare to the Sep '25 ebitda of ₹ 0.01 crore. This represent the growth of 3100% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The net profit of Shree Ganesh Biotech India Ltd changed from ₹ 0.77 crore to ₹ 0.32 crore over 7 quarters. This represents a CAGR of -39.45% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Shree Ganesh Biotech India Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' with the Registrar of Companies, West Bengal.
The Company got the Certificate of Commencement of Business on September 14, 1982.
The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business. In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010.
The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited.
Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited.

FAQs for the comparison of Procter & Gamble Health Ltd and Shree Ganesh Biotech India Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Shree Ganesh Biotech India Ltd?

Market cap of Procter & Gamble Health Ltd is 8,854 Cr while Market cap of Shree Ganesh Biotech India Ltd is 24 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Shree Ganesh Biotech India Ltd?

The stock performance of Procter & Gamble Health Ltd and Shree Ganesh Biotech India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Shree Ganesh Biotech India Ltd?

As of May 6, 2026, the Procter & Gamble Health Ltd stock price is INR ₹5334.05. On the other hand, Shree Ganesh Biotech India Ltd stock price is INR ₹0.61.

How do dividend payouts of Procter & Gamble Health Ltd and Shree Ganesh Biotech India Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Shree Ganesh Biotech India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.